Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
84 hedge funds and large institutions have $73.8M invested in Enzo Biochem, Inc. in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 6 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
21% more capital invested
Capital invested by funds: $61.1M → $73.8M (+$12.7M)
2% more funds holding
Funds holding: 82 → 84 (+2)
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
87% less call options, than puts
Call options by funds: $364K | Put options by funds: $2.86M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$904K |
| 2 |
VCA
VIEX Capital Advisors
Sunny Isles Beach,
Florida
|
+$339K |
| 3 |
BlackRock
New York
|
+$318K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$261K |
| 5 |
JP Morgan Chase
New York
|
+$242K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
-$750K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$478K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$264K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$215K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$131K |
ENZ Hedge Fund Activity: Q4 2020 in Review
84 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2020, worth a combined $73.8M — up 21% from $61.1M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ENZ positions and 6 closed out — a net gain of 2 holders — while 25 added to existing stakes and 24 trimmed.
The largest buyer was Roumell Asset Management, adding an estimated $904K. The largest seller was Evermore Global Advisors, cutting an estimated $750K.
- 84 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2020, up from 82 in Q3 2020.
- Funds reported $73.8M of Enzo Biochem, Inc. stock for Q4 2020, up 21% quarter-over-quarter.
- 8 funds opened new Enzo Biochem, Inc. positions in Q4 2020 and 6 closed out, a net change of +2 holders.
- The largest Enzo Biochem, Inc. buyer in Q4 2020 was Roumell Asset Management, an estimated $904K added.
- The largest Enzo Biochem, Inc. seller in Q4 2020 was Evermore Global Advisors, an estimated $750K sold.
Based on aggregated 13F filings for Q4 2020.